-
Market Longs Are Strong 01-18-2011
Tuesday, January 18, 2011 - 7:22pm | 874Cusick's Corner The market has held up again and is potentially setting up a nice upside challenge. This is the blow off that we have been waiting for and the catalyst could be AAPL's earnings. While the sustainability of a blow off run will come into question, the mere fact is that the longs are...
-
Wright Intros DARCO in Japan - Analyst Blog
Tuesday, January 18, 2011 - 6:31pm | 615Orthopedic devices maker Wright Medical (WMGI) has introduced the DARCO foot and ankle plating system in Japan. The launch represents an important milestone for the company's foot and ankle surgical products business. The product is marketed in the U.S. and other major international markets since...
-
Wright Intros DARCO in Japan - Analyst Blog
Tuesday, January 18, 2011 - 6:07pm | 615Orthopedic devices maker Wright Medical (WMGI) has introduced the DARCO foot and ankle plating system in Japan. The launch represents an important milestone for the company's foot and ankle surgical products business. The product is marketed in the U.S. and other major international markets since...
-
SurModics Upped to Neutral - Analyst Blog
Tuesday, January 18, 2011 - 5:01pm | 382We are upgrading SurModics Inc. (SRDX) to ‘Neutral' from ‘Underperform' following the efforts of the company to emerge from the below-par performances delivered over the past few quarters. Our target price on the stock is $13.00. We are encouraged by the company's move to explore options...
-
Bad News Easily Absorbed 01-18-2011
Tuesday, January 18, 2011 - 4:58pm | 1007Cusick's Corner This market can be characterized as a roaring bull market where bad news can be absorbed and good news sustains the move up. However, really good news starts to raise some red flags, especially for seasoned traders. This market is looking like it will challenge and break the upper...
-
SurModics Upped to Neutral - Analyst Blog
Tuesday, January 18, 2011 - 4:43pm | 382We are upgrading SurModics Inc. (SRDX) to ‘Neutral' from ‘Underperform' following the efforts of the company to emerge from the below-par performances delivered over the past few quarters. Our target price on the stock is $13.00. We are encouraged by the company's move to explore options...
-
Medtronic Revises Design of CoreValve Pivotal Trial
Tuesday, January 18, 2011 - 2:16pm | 88Medtronic, Inc. (NYSE: MDT) today announced it has received conditional approval from the U.S. Food and Drug Administration to modify its CoreValve U.S. Pivotal Clinical Trial. In the revised design, the trial will assess the CoreValve System in extreme risk patients in a single arm study with a...
-
BSX Pins Hopes on Neuro (revised) - Analyst Blog
Tuesday, January 18, 2011 - 1:01pm | 460Boston Scientific Corporation (BSX) is currently in an acquisition spree, the latest being Boston based Intelect Medical for $78 million. Intellect is presently developing advanced neuromodulation technologies for deep brain stimulation (DBS) therapy. However, considering the company's current...
-
BSX Pins Hopes on Neuro (revised) - Analyst Blog
Tuesday, January 18, 2011 - 12:36pm | 460Boston Scientific Corporation (BSX) is currently in an acquisition spree, the latest being Boston based Intelect Medical for $78 million. Intellect is presently developing advanced neuromodulation technologies for deep brain stimulation (DBS) therapy. However, considering the company's current...
-
Options Brief: Thoratec Corporation (THOR)
Tuesday, January 18, 2011 - 11:46am | 90Shares of Thoratec Corporation (NASDAQ: THOR) are lower on the session by 2.84%, trading at $26.72. Overall put volume is now running at 12.79x the daily average, with 19% of all call puts traded being purchases on the offer. 2,085 contracts have traded on the session so far. Thoratec Corporation...
-
Piper Jaffray Reiterates Overweight on Clinical Data (CLDA)
Tuesday, January 18, 2011 - 10:26am | 114Piper Jaffray is out with its research report on Clinical Data (NASDAQ: CLDA) reiterating its Overweight rating. In its report, Piper Jaffray notes, "We remain optimistic that vilazodone will receive FDA approval by Monday, January 24th. We believe the drug has shown sufficient efficacy for...
-
St. Jude To Launch Quadra CRT-D Sooner Than Expected?
Tuesday, January 18, 2011 - 10:06am | 192Jefferies & Company has published a research report on St. Jude Medical (NYSE: STJ) after the company talks suggested a sooner launch of its Quadra CRT-D device in the U.S. at the Boston AF Meeting. In the report, Jefferies writes "Several clinicians and industry reps we spoke with at the...
-
Earnings Preview: Intuitive - Analyst Blog
Tuesday, January 18, 2011 - 10:01am | 957Intuitive Surgical (ISRG) is slated to report its fourth quarter and fiscal 2010 results on Thursday, January 20, 2011. The current Zacks Consensus Estimates for the fourth quarter and fiscal year are $2.25 and $8.70, representing an estimated 15.45% and 39.63% annualized growth, respectively....
-
Accuray Appoints Chief Marketing Officer
Tuesday, January 18, 2011 - 9:34am | 30Accuray Incorporated (Nasdaq: ARAY) announced today that Eric Pauwels has joined Accuray as Senior Vice President and Chief Marketing Officer, effective January 17, 2011.
-
Earnings Preview: Intuitive - Analyst Blog
Tuesday, January 18, 2011 - 9:30am | 957Intuitive Surgical (ISRG) is slated to report its fourth quarter and fiscal 2010 results on Thursday, January 20, 2011. The current Zacks Consensus Estimates for the fourth quarter and fiscal year are $2.25 and $8.70, representing an estimated 15.45% and 39.63% annualized growth, respectively....